GC Biopharma signs ₩59.2bn influenza vaccine supply contract

GC Biopharma · KOSPI · 006280 · Nov 2, 2026 · Supply contracts

GC Biopharma filed a supply contract for influenza vaccines with VaxThera Zona Franca S.A.S., with a contract amount of ₩59.2bn. The filing reports the contract as 3.0% of revenue, and the contract period runs from Oct 30, 2026 to Oct 30, 2036. The filing date is Nov 2, 2026.

Key facts

Contract nameInfluenza vaccine supply contract
CounterpartyVaxThera Zona Franca S.A.S.
Contract amount₩59.2bn
% of revenue (as reported)3.0%
Period startOct 30, 2026
Period endOct 30, 2036

Comparison

Amount as % of FY2025 revenue (calculated)3.0%
Revenue 2025₩2.0tn
Revenue 2024₩1.7tn
Revenue 2023₩1.6tn

Key metrics

Supply contracts

Supply contracts, last 12 months₩59.2bn As of Nov 2, 2026 Source 1
Supply contracts vs prior-year revenue3.0% As of Nov 2, 2026 Source 1
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Related filings

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)